IBDEI0LR ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10665,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10665,1,4,0)
 ;;=4^607.84
 ;;^UTILITY(U,$J,358.3,10665,1,5,0)
 ;;=5^Erectile Dysfunction
 ;;^UTILITY(U,$J,358.3,10665,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,10666,0)
 ;;=530.81^^67^682^30
 ;;^UTILITY(U,$J,358.3,10666,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10666,1,4,0)
 ;;=4^530.81
 ;;^UTILITY(U,$J,358.3,10666,1,5,0)
 ;;=5^GERD
 ;;^UTILITY(U,$J,358.3,10666,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,10667,0)
 ;;=389.9^^67^682^32
 ;;^UTILITY(U,$J,358.3,10667,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10667,1,4,0)
 ;;=4^389.9
 ;;^UTILITY(U,$J,358.3,10667,1,5,0)
 ;;=5^Hearing Loss NOS
 ;;^UTILITY(U,$J,358.3,10667,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,10668,0)
 ;;=784.0^^67^682^31
 ;;^UTILITY(U,$J,358.3,10668,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10668,1,4,0)
 ;;=4^784.0
 ;;^UTILITY(U,$J,358.3,10668,1,5,0)
 ;;=5^Headaches
 ;;^UTILITY(U,$J,358.3,10668,2)
 ;;=^54133
 ;;^UTILITY(U,$J,358.3,10669,0)
 ;;=070.54^^67^682^33
 ;;^UTILITY(U,$J,358.3,10669,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10669,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,10669,1,5,0)
 ;;=5^Hepatitis C
 ;;^UTILITY(U,$J,358.3,10669,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,10670,0)
 ;;=272.4^^67^682^34
 ;;^UTILITY(U,$J,358.3,10670,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10670,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,10670,1,5,0)
 ;;=5^Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,10670,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,10671,0)
 ;;=272.2^^67^682^35
 ;;^UTILITY(U,$J,358.3,10671,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10671,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,10671,1,5,0)
 ;;=5^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,10671,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,10672,0)
 ;;=401.9^^67^682^36
 ;;^UTILITY(U,$J,358.3,10672,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10672,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,10672,1,5,0)
 ;;=5^Hypertension NOS
 ;;^UTILITY(U,$J,358.3,10672,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,10673,0)
 ;;=244.9^^67^682^37
 ;;^UTILITY(U,$J,358.3,10673,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10673,1,4,0)
 ;;=4^244.9
 ;;^UTILITY(U,$J,358.3,10673,1,5,0)
 ;;=5^Hypothyroidism NOS
 ;;^UTILITY(U,$J,358.3,10673,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,10674,0)
 ;;=790.21^^67^682^38
 ;;^UTILITY(U,$J,358.3,10674,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10674,1,4,0)
 ;;=4^790.21
 ;;^UTILITY(U,$J,358.3,10674,1,5,0)
 ;;=5^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,10674,2)
 ;;=^329895
 ;;^UTILITY(U,$J,358.3,10675,0)
 ;;=790.5^^67^682^40
 ;;^UTILITY(U,$J,358.3,10675,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10675,1,4,0)
 ;;=4^790.5
 ;;^UTILITY(U,$J,358.3,10675,1,5,0)
 ;;=5^Liver Enzymes,Elevated
 ;;^UTILITY(U,$J,358.3,10675,2)
 ;;=^273402
 ;;^UTILITY(U,$J,358.3,10676,0)
 ;;=724.2^^67^682^41
 ;;^UTILITY(U,$J,358.3,10676,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10676,1,4,0)
 ;;=4^724.2
 ;;^UTILITY(U,$J,358.3,10676,1,5,0)
 ;;=5^Low Back Pain,Chronic
 ;;^UTILITY(U,$J,358.3,10676,2)
 ;;=^71885
 ;;^UTILITY(U,$J,358.3,10677,0)
 ;;=412.^^67^682^45
 ;;^UTILITY(U,$J,358.3,10677,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10677,1,4,0)
 ;;=4^412.
 ;;^UTILITY(U,$J,358.3,10677,1,5,0)
 ;;=5^Myocardial Infarction-Old
 ;;^UTILITY(U,$J,358.3,10677,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,10678,0)
 ;;=250.60^^67^682^47
 ;;^UTILITY(U,$J,358.3,10678,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10678,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,10678,1,5,0)
 ;;=5^Neuropathy,Diabetic
 ;;^UTILITY(U,$J,358.3,10678,2)
 ;;=^331803^357.2
 ;;^UTILITY(U,$J,358.3,10679,0)
 ;;=V15.81^^67^682^48
